Search Results 401-410 of 20482 for hepatitis

  1. Digestive Diseases Physicians - Medical Professionals - Mayo Clinic

    Cholangiocarcinoma, Primary sclerosing cholangitis, Hepatitis C, Hepatitis B, Hepatocellular carcinoma, Primary biliary cholangitis, Nonalcoholic fatty ...

  2. Mycophenolate (oral route) - Side effects & dosage - Mayo Clinic

    Hepatitis B or C infection, history of or; Stomach or bowel problems—Use with caution. May make these conditions worse. Infection—May decrease your ability ...

  3. Medical Research & Education - Mayo Clinic News Network

    ... hepatitis. Jay Furst. February 15, 2022. Research. Regenerative Medicine Minnesota awards 5 research grants to Mayo Clinic. Mayo Clinic Staff. February 15, 2022.

  4. Ombitasvir, paritaprevir, ritonavir and dasabuvir (oral route) - Side effects & dosage - Mayo Clinic

    For chronic hepatitis C virus infection, with or without ribavirin: Adults—2 pink tablets once a day (taken in the morning) and 1 beige tablet two times a day ( ...

  5. Samar H. Ibrahim, M.B., Ch.B. - Doctors and Medical Staff - Mayo Clinic

    Nonalcoholic fatty liver disease · Autoimmune hepatitis, primary sclerosing cholangitis and immunoglobulin G4 associated cholangitis: the spectrum of autoimmune ...

  6. Cirrhosis Clinical Trials - Mayo Clinic Research

    ... hepatitis C virus (HCV) study or commercially at selected sites. Once enrolled, participants will be followed for up to 5 years. A Study To Evaluate At-Home ...

  7. Images - Membrane Trafficking in Disease - Mayo Clinic Research

    2.15 cells are stably infected with HBV and secrete CD63 positive exosomes (green), which can also contain hepatitis B virions, as they migrate. The ...

  8. The Alcoholic Liver Disease/Nonalcoholic Fatty Liver Disease Index (ANI) - Medical Professionals - Mayo Clinic

    Learn more about research related to ANI. MELD calculations may also be performed for the 90-days mortality rate of Alcoholic Hepatitis. Related Content ...

  9. Keith D. Robertson, Ph.D. - Mayo Clinic Faculty Profiles

    Environmental factors such as hepatitis virus infection or high-fat diets largely drive liver disease and hepatocellular cancer. These exposures ...

  10. A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis - Mayo Clinic

    Active hepatitis B infection as defined by the presence of hepatitis B surface antigen (HBsAg) or presence of hepatitis B virus DNA;; c. Hepatitis C as ...